Short-Term Market Volatility Could Provide Long-Term Investing Opportunities
Investing Insights
00:00
Pharmaceutical Sales Expectations, Stock Value Estimates, and Medicare Prescription Cost Reductions
Exploring Morningstar's projection of a pharmaceutical company's sales exceeding $60 billion alongside the success of its drugs, including Eli Lilly's breast cancer medication. Discussion also includes Morningstar's increased stock value estimation and the impact of recent legislation on cutting prescription expenses for Medicare beneficiaries.
Transcript
Play full episode
